Idiopathic Intracranial Hypertension
22
4
7
7
Key Insights
Highlights
Success Rate
70% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
13.6%
3 terminated out of 22 trials
70.0%
-16.5% vs benchmark
18%
4 trials in Phase 3/4
57%
4 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (22)
Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
Evaluating Raised Intracranial Pressure Using MR Elastography
The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure
MR Lymphatic Imaging in Idiopathic Intracranial Hypertention
Prospective Ocular Imaging for Intracranial Pressure Evaluation
Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
Ocular Perfusion in Patients With Idiopathic Intracranial Hypertension
ICP & Outflow Study
Biomarkers in the Etiology of Idiopathic Intracranial Hypertension
A Trial to Determine the Efficacy and Safety of Presendin in IIH
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
Venous Sinus Stenting With the River Stent in IIH
Assessment of ICP in Idiopathic Intracranial Hypertension Using Transocular Ultrasound and Transcranial Doppler
Surgical Idiopathic Intracranial Hypertension Treatment Trial
Outcome of Cerebral Venous Sinuses Stenting on Idiopathic Intracranial Hypertension
Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
An RCT of Bariatric Surgery vs a Community Weight Loss Programme for the Sustained Treatment of IIH
The Effects of MAP and EtCO2 on Venous Sinus Pressures
Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension Treatment Trial